Mondaq USA: Food, Drugs, Healthcare, Life Sciences > Food and Drugs Law
Seyfarth Shaw LLP
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.
Lewis Brisbois Bisgaard & Smith LLP
The Missouri General Assembly passed multiple bills this legislative session which will have an impact on employers.
Holland & Knight
The Centers for Medicare & Medicaid Services (CMS) has announced a new proposed reimbursement model for certain Medicare Part B drugs and biologicals.
Dickinson Wright PLLC
On November 6, Michigan voters approved Proposal 1, legalizing the use of marihuana by individuals 21 years of age and older.
Reed Smith
Plaintiff Kevin McCann launched a putative class action against The UCAN Company ("UCAN")
Dickinson Wright PLLC
Following the passage of Proposal 1 on the 2018 Michigan mid-term ballot, Michigan became the 10th state to legalize, regulate, and tax cannabis use.
Foley Hoag LLP
In a wide-ranging speech on CMS's efforts to lower Medicaid drug costs, Administrator Seema Verma announced yesterday that CMS ...
Reed Smith
Today we have another guest post by long-time friend of the blog, Dick Dean, and his colleague at Tucker, Ellis, Mike Ruttinger.
Sheppard Mullin Richter & Hampton
This part 6 of our 7 part series focuses on the provisions regarding dual special needs plans ("D-SNPs") released by the Centers for Medicare and Medicaid Services ("CMS") in the proposed rule...
Foley & Lardner
On November 2, 2018, CMS released an on-line display copy of its Outpatient Prospective Payment System (OPPS) Final Rule implementing payment changes effective January 1, 2019.
Troutman Sanders LLP
On December 5, 2018, FDA will hold a public hearing to discuss its efforts to eliminate youth e-cigarette and other tobacco product use.
Shearman & Sterling LLP
Associate Timothy Slattery (Antitrust-Washington, DC) has contributed to the Pharmaceutical Industry Antitrust Handbook (2nd Ed.) published by the American Bar Association
Seyfarth Shaw LLP
One of the latest efforts by a municipality to address public health concerns by requiring warnings on certain products may be revived depending on the outcome of a recent rehearing before
Seyfarth Shaw LLP
Michigan becomes the tenth state to legalize cannabis on a recreational level, and Missouri and Utah now join thirty-one other states who have legalized medical marijuana.
Thompson Coburn LLP
All commercial cannabis activity shall be conducted between licensees.
Sheppard Mullin Richter & Hampton
Lynsey Mitchel By Eric Klein, Lynsey Mitchel and John Tilton* on November 13, 2018 Posted in Healthcare Law, Prescription Drug Issues California recently passed Assembly Bill 315 to create greater regulatory oversight of pharmacy benefit managers ("PBMs").
Foley & Lardner
In Yeda Research & Development Co., v. Mylan Pharmaceuticals Inc., the Federal Circuit affirmed the decisions of the USPTO PTAB finding three Copaxone patents invalid as obvious in parallel IPR proceedings.
Holland & Knight
The Centers for Medicare & Medicaid Services (CMS) has issued the Calendar Year (CY) 2019 Final Rule that updates payment rates and policy changes in the Hospital Outpatient Prospective Payment System
Littler Mendelson
As has become common in recent years (and despite marijuana's continued illegality under federal law), citizens in several states voted on marijuana-related measures this election cycle.
Ford & Harrison LLP
Executive Summary: The Department of Labor's Wage and Hour Division (WHD) has announced it will no longer apply the "80/20 rule" to tipped employees ...
Latest Video
Most Popular Recent Articles
BakerHostetler
Partners Carl Hittinger and Jeffry Duffy authored an article published by The Legal Intelligencer on July 27, 2018.
Foley Hoag LLP
The symbol at right is one of the three candidate food labeling symbols indicating the presence of "bioengineered foods" being proposed ...
Thompson Coburn LLP
There are three initiatives on Missouri's November 6, 2018, ballot that seek to make medical cannabis legal under Missouri state law.
Thompson Coburn LLP
Three initiatives on Missouri's November 6, 2018, ballot seek to make medical marijuana or medical cannabis legal under Missouri state law.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
If you read part one of this series, you appreciate that it is imperative that all individuals involved in drug development — including scientific, regulatory, marketing, and financial personnel...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
You are probably familiar with using trademarks, trade secrets and even utility patents to protect culinary innovations.
Seyfarth Shaw LLP
The FDA Reauthorization Act of 2017 (FDARA) created a new type of 180-day exclusivity for ANDA applicants applying for approval of certain drugs designated as Competitive Generic Therapies.
Reed Smith
The Office of the Inspector General (OIG) published a report in September 2018 after a review of the Food and Drug Administration's (FDA) policies, procedures, and guidance relating to cybersecurity reviews of networked medical devices
Skadden, Arps, Slate, Meagher & Flom (UK) LLP
For the past several years, Republican majorities in the House of Representatives and Senate have dictated the agenda of Congress
Oblon, McClelland, Maier & Neustadt, L.L.P
Teva Pharmaceutical USA, Inc. filed a Complaint and Motion for Preliminary Injunction in the U.S. District Court for the District of Columbia, ...
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with